Suscribirse

Multicenter Study of Knowledge About Human Papilloma Virus and Attitudes Among Emergency Department Patients - 07/08/11

Doi : 10.1016/j.jpag.2009.03.001 
Jennifer C. Millen, MD, MPH 1, 2, Adit A. Ginde, MD, MPH 3, Angela T. Anderson, BS 2, Penny Fang, BA 2, Carlos A. Camargo, MD, DrPH 2,
1 Department of Emergency Medicine, Brigham and Women’s Hospital, Boston, Massachusetts 
2 Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts 
3 Department of Emergency Medicine, University of Colorado Denver School of Medicine, Aurora, Colorado 

Address correspondence to: Carlos A. Camargo, Jr., MD, DrPH Massachusetts General Hospital, 326 Cambridge Street, Suite 410, Boston, MA 02114

Abstract

Study Objective

We sought to evaluate knowledge of human papilloma virus (HPV) and attitudes toward the HPV vaccine among emergency department (ED) patients.

Design

Cross-sectional survey.

Setting

Three Boston EDs.

Participants

We enrolled consecutive patients during two 24-hour periods at each site.

Interventions

None.

Main Outcome Measures

Knowledge of HPV and attitudes toward the HPV vaccine.

Results

We enrolled 387 patients (81% of eligible). Overall, 242 (63%) participants had heard of HPV and 203 (52%) supported state-mandated vaccination. In the multivariate model, characteristics associated with lower awareness of HPV were: (1) older age (compared to age18-26-years: OR 0.45 [95%CI, 0.20–0.99] for age 27–44 years, OR 0.26 [95%CI, 0.12–0.56] for age 45–64 years, and OR 0.10 [95%CI, 0.04–0.28] for age 65 year or older), (2) black race (compared to white: OR 0.31 [95%CI, 0.15–0.64]); and (3) lower annual household income (OR 0.39 [95%CI, 0.19–0.81] for $40,000 or less). Of those people who had heard of HPV, 82% knew of its relationship to cervical cancer, but only 61% thought it was a sexually transmitted disease (STD). Support for state-mandated vaccination was higher among participants who knew that HPV was an STD (OR 2.9 [95%CI 1.7–5.0]), but was not higher among those who had heard of HPV (OR 0.64 [95%CI 0.34–1.2]) or who knew that HPV causes cervical cancer (OR 0.85 [95%CI 0.45–1.6]).

Conclusions

Support for state-mandated HPV vaccination appears to be driven more by the knowledge that HPV is an STD than by its role in cervical cancer. Awareness that HPV is transmitted through sexual activity does not decrease support for vaccination and may actually enhance it.

El texto completo de este artículo está disponible en PDF.

Key Words : HPV, Vaccine, Sexually transmitted diseases, Emergency medicine, Public health


Esquema


© 2009  North American Society for Pediatric and Adolescent Gynecology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 22 - N° 6

P. 356-359 - décembre 2009 Regresar al número
Artículo precedente Artículo precedente
  • Cervical Dysplasia and Associated Risk Factors in a Juvenile Detainee Population
  • S. Gander, V. Scholten, I. Osswald, M. Sutton, R. van Wylick
| Artículo siguiente Artículo siguiente
  • Management of Ovarian Dermoid Cysts in the Pediatric and Adolescent Population
  • Ingrid Savasi, Judith A. Lacy, J. Ted Gerstle, Derek Stephens, Sari Kives, Lisa Allen

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.